This episode features highlights from the 2021 Midyear Clinical Meeting where content matter experts from the Clinical Specialists and Scientists review the pharmacokinetic and pharmacodynamic characteristics a pharmacist must take into consideration when designing.
HOST
Vicki Basalyga, PharmD MAS, BCPS, BCPPS is the Director of Member Relations for the Clinical Specialists and Scientists at ASHP. In addition to her Director role, Vicki assists in clinical policy development as the Secretary for the Council on Therapeutics, serves as a representative for ASHP on numerous national clinical initiatives and works with members to create essential tools and resources for leaders, practitioners and educators.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.